Gemfibrozil 75834-0131-18
- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 15, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA203266
Need to source Gemfibrozil? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gemfibrozil | 600 mg/1 |
Drug Class
Peroxisome Proliferator Receptor alpha Agonist [EPC]PPAR alpha [CS]Peroxisome Proliferator Receptor alpha Agonist [EPC]
Selected Package
75834-0131-18Selected180 TABLET in 1 BOTTLE (75834-131-18)
Other packages for this product(2)
500 TABLET in 1 BOTTLE (75834-131-05)
60 TABLET in 1 BOTTLE (75834-131-60)